PACE GARY W

Track

Insider profile

Performance

Overall performance
4.1
Performance over holding periods
4.1
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 57% 68% 82%
Transactions
23 70% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
PACE GARY W's trades of Cardiff Oncology Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-16 2026-07-14
B Purchase
72,312 +20.5%
188.88
US$2,586,517 		72,312 +20.5% 188.88 US$2,586,517
2026-06-22 2026-06-18
B Purchase
64,010 -17.2%
481.48
US$137,967 		64,010 -17.2% 481.48 US$137,967
2026-06-22 2026-06-18
B Purchase
4,876 +23.9%
17.61
US$3,929,875 		4,876 +23.9% 17.61 US$3,929,875
2025-07-31 2025-07-30
B Purchase
15,000 +1.1%
2.45
US$36,750 		15,000 +1.1% 2.45 US$36,750
2025-07-31 2025-07-30
B Purchase
275,000 +26.0%
2.45
US$673,750 		275,000 +26.0% 2.45 US$673,750
2024-12-12 2024-12-11
B Purchase
11,500 +1.1%
2.60
US$29,900 		11,500 +1.1% 2.60 US$29,900
2024-12-12 2024-12-11
B Purchase
350,115 +50.2%
2.60
US$910,299 		350,115 +50.2% 2.60 US$910,299
2024-03-08 2024-03-08
S Sale
90,000 -80.3%
30.60
US$2,754,000 		90,000 -80.3% 30.60 US$2,754,000
2024-03-08 2024-03-07
S Sale
28,257 -20.1%
30.81
US$870,598 		28,257 -20.1% 30.81 US$870,598
2024-03-08 2024-03-06
S Sale
1,066 -0.8%
29.67
US$31,628 		1,066 -0.8% 29.67 US$31,628
2024-03-06 2024-03-06
PrS Proposed sale
120,483
29.67
US$3,575,000 		120,483 29.67 US$3,575,000
2023-12-19 2023-12-19
B Purchase
30,000 +4.5%
1.37
US$41,100 		30,000 +4.5% 1.37 US$41,100
2023-11-14 2023-11-10
B Purchase
22,950 +3.6%
0.98
US$22,491 		22,950 +3.6% 0.98 US$22,491
2023-05-15 2023-05-11
S Sale
5,015 -3.5%
41.78
US$209,527 		5,015 -3.5% 41.78 US$209,527
2023-05-11 2023-05-11
PrS Proposed sale
5,015
41.78
US$209,519 		5,015 41.78 US$209,519
2022-09-19 2022-09-15
B Purchase
150,000 +30.3%
1.71
US$256,500 		150,000 +30.3% 1.71 US$256,500
2022-03-01 2022-03-01
S Sale
1,359 -1.0%
67.75
US$92,072 		1,359 -1.0% 67.75 US$92,072
2022-03-01 2022-02-28
S Sale
28,641 -18.1%
66.83
US$1,914,078 		28,641 -18.1% 66.83 US$1,914,078
2021-03-24 2021-03-23
B Purchase
2,500 +0.5%
10.31
US$25,775 		2,500 +0.5% 10.31 US$25,775
2021-03-24 2021-03-23
B Purchase
2,500 +0.5%
10.21
US$25,525 		2,500 +0.5% 10.21 US$25,525
2021-03-24 2021-03-23
B Purchase
5,000 +1.1%
10.20
US$51,000 		5,000 +1.1% 10.20 US$51,000
2021-03-19 2021-03-18
B Purchase
2,000 +0.4%
10.54
US$21,080 		2,000 +0.4% 10.54 US$21,080
2021-03-19 2021-03-18
B Purchase
1,000 +0.2%
10.58
US$10,580 		1,000 +0.2% 10.58 US$10,580
2021-03-04 2021-03-04
B Purchase
1,500 +0.3%
9.27
US$13,898 		1,500 +0.3% 9.27 US$13,898
2020-09-17 2020-09-16
B Purchase
850 +0.2%
5.71
US$4,854 		850 +0.2% 5.71 US$4,854
2020-09-17 2020-09-16
B Purchase
1,700 +0.4%
5.69
US$9,673 		1,700 +0.4% 5.69 US$9,673
2020-05-13 2020-05-11
B Purchase
447,761 +inf%
1.34
US$600,000 		447,761 +inf% 1.34 US$600,000
2004-05-17 2004-05-13
US Resmed Inc (RMD)
S Sale
5,000 -5.8%
47.46
US$237,306 		5,000 -5.8% 47.46 US$237,306